OUHSC Research News – Monday, August 29, 2022
Notices and Reminders
ORA Notice: The Office of Research Administration (ORA) is pleased to provide to our faculty and staff the training videos focused on the compliance topics listed below. These trainings were offered as part of a “Compliance and Research Workshop” to ensure that the OUHSC research community was appropriately informed of the various regulations that govern federally-funded research. To access the videos and download the slides, please click here.
- Office of Compliance
- Export Controls and Foreign Influence
- The False Claims Act
- Intellectual Property at the University of Oklahoma
- Office of Human Research Participant Protection (HRPP) and Institutional Review Board (IRB)
SoonerTrack II Live Q&A sessions
Have a question about the new SoonerTrack system? The Office of Research Administration (ORA) invites you to attend the SoonerTrack II Q&A session below, where you will have the opportunity to ask questions and receive answers from the subject matter experts. Registration is required. This session will be hosted virtually via Zoom. Questions may also be submitted ahead of time to soonertrackhelpdesk@ouhsc.edu.
August 31, 2022 10:30 AM – 11:30 AM Register here
Workshops and Seminars
Lunch and Learn - Patents 101: First Do No Harm - How to Write and Speak about Your Invention Without Losing U.S. or Foreign Patent Rights
Date: Tuesday, August 30, 2022, 12:00 p.m. (CDT)
Description: Learn critical information about how to protect your invention and your patent rights.
This month’s speaker is Dr. Chris Corbett, Director of Intellectual Property for OTC.
Topics
- What is a patent and what does a patent protect?
- Patenting in a university.
- Requirements for patentability.
- What is “prior art”?
- What is a public disclosure?
- How to publish without hurting your patent rights.
- Key milestones of the patenting process.
Ideating for team research in Health, Well-being and the Built Environment (Workshop 1 of 2)
Date/Time: Friday, September 23, 9:00 a.m. -12:00 pm Central
One sentence summary of the event: This first of two interactive workshops will gather researchers from OU Norman and OU HSC to share their expertise and ideate around collaborative research projects in the area of health, well-being, and the built environment.
Description: Join CFE, along with Susan Sisson (Allied Health) and Angela Person (Gibbs College), in the first of two workshops to jump-start ideas for collaborative proposals related to health, well-being, and the built environment. Participation in both workshops is not required, but suggested.
During this session, OU researchers will share their expertise, learn about funding opportunities in the area of health, well-being, and the built environment, exchange ideas across disciplines and brainstorm collaborative proposals for an internal seed grant funding opportunity aimed at securing external funding in the future. Faculty from OU Norman and OU HSC are encouraged to attend to learn more.
Event Venue/Location: In-person at the OU HSC campus. Location information follows registration.
Registration link: https://ousurvey.qualtrics.com/jfe/form/SV_4OAifunZajSEKUu
RFP: https://bit.ly/3R8Prc4
Point of contact: Clara Smith, clara.smith@ou.edu
Team building and research development for projects in health, well-being, and the built environment (Workshop 2 of 2)
Date/Time: Friday, October 21, 9:00 a.m. -12:00 pm Central
One sentence summary of the event: This second of two interactive workshops has OU Norman and OU HSC researchers pitch their collaborative research ideas and participate in activities to further trans-disciplinary aspects and align with funding opportunities in the area of health, well-being, and the built environment.
Description: Join CFE, along with Susan Sisson (Allied Health) and Angela Person (Gibbs College), in the second of two workshops to further develop ideas for collaborative proposals related to health, well-being, and the built environment. Participation in both workshops is not required, but suggested.
During this session, OU researchers will share the basic idea of their team research, receive feedback from grant writing experts, develop a plan to reach out to program managers, and further prepare for the internal seed grant funding opportunity aimed at securing external funding in the future. Don't have something to pitch or didn't attend the first workshop? Faculty from OU Norman and OU HSC are encouraged to attend to learn more.
Event Venue/Location: In-person on the OU Norman campus. Location information follows registration
Registration link: https://ousurvey.qualtrics.com/jfe/form/SV_bjgGl4HK21Fr14i
RFP: https://bit.ly/3R8Prc4
Point of contact: Clara Smith, clara.smith@ou.edu [same person as for workshop 1]
NIH Webinar II: Diving Deeper into the New NIH Data Management and Sharing Policy
Date: Thursday, September 22, 2022 / 12:30 - 2:30 PM (Central)
Description: The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an engaging and interactive webinar focused on the new DMS policy which goes into effect on January 25, 2023. In this second webinar of the series, we will expand upon the information presented in the first webinar and dive deeper into topics including privacy protections for data from human participants and justifiable limitations on sharing data. Don't miss this valuable opportunity to hear policy experts provide the latest information and to get your questions answered.
Registration: https://vfairs.zoom.us/webinar/register/WN_3y9GFMc2SsWpv2GhIzOGsg
OUHSC Funding Opportunities
OSCTR TPIR Trainee Program
Seeking applicants for the ninth year of the research training program Translating Practice into Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, basic scientists, and community health professionals and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to translate their clinical observations and ideas for improving practice into practical and feasible research projects. Attached is a detailed description and application due September 23, 2022.
Link to the full announcement: http://octsi.ouhsc.edu/Translating Practice into Research
Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit
Description: Grant proposals are being accepted for the Fall cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $125,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Submission Checklist provided with this notice.
Deadline: October 3, 2022 at 5 pm CST
Link to the full announcement or a flyer: Please refer to the attached flyer.
Trainee Research Conference and Workshop Award
Description: The Stephenson Cancer Center (SCC) is pleased to offer Research Conference and Workshop awards for participation in professional meetings and workshops. These awards are available to graduate students, professional students, and postdoctoral fellows at the University of Oklahoma Health Sciences Center (OUHSC) and University of Oklahoma (OU) main campus. This includes medical students, residents and fellows, as well as fulltime faculty who are currently enrolled in a graduate or professional degree program. The SCC intends to give up to 8 of these awards to cover meetings and conferences held between November 1, 2022 and April 30, 2023. See below for more information.
Financial Support: Up to $1000 will be awarded per applicant to support the registration fees, airfare, hotel and other related expenses. The above and other qualifying expenses will be reimbursed per the University of Oklahoma’s Travel Reimbursement policy.
How to Apply: Interested applicants should complete the Online Application Form and include all required application materials. Complete applications must be submitted on or before the following application deadlines:
- September 18, 11:59 PM CST, for Winter/Spring Meetings or Workshops being held between November 1 and April 30.
We understand that trainees may not be aware of abstract acceptance and other details at by the above deadline. Please still apply. If awarded, trainee should update the Program Manager as details are known.
More information: Please contact the Program Manager. Please refer the attached flyer.
Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).
- ELI Lilly is seeking druggable targets for weight loss, in particular approaches focused on appetite modulation, energy expenditure and mechanisms synergistic with GLP-1. All mechanisms and modalities are of interest as is drug repurposing. Out of scope includes plant/food based approaches and probiotics/microbiome targeting (unless weight loss is robust). Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 08/25).
- A multinational restorative dentistry company is looking for novel 3D scanning technologies that can be applied to the oral environment, for use to improve methods for structured light scanning (i.e. improved speed, reduced costs, improved accuracy, and ease of use). Technology should be able to achieve resolution in the 25-50 micron range and acquire color imaging. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information. (deadline 09/02).
NIH Notices
- Notice of Need to Expire and Reissue RFA-AT-23-004 Research Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed) to Correct Review Criteria
(NOT-AT-22-029)
- Notice of NCCIH Technical Assistance Webinar for RFA-AT-23-005, Research Resource Center to Build an Open-Access Repository and Database for Anatomical and Physiological Correlates of Acupoints (U24, Clinical Trial Optional)
(NOT-AT-22-032)
- Notice of Pre-Application Webinar for RFA-CA-22-031 and RFA-CA-22-032 for Consortium on Translational Research in Early Detection of Liver Cancer
(NOT-CA-22-121)
- Change of Application Due Date for PAR-22-114, Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
(NOT-CA-22-122)
- Notice of Pre-Application Technical Assistance Webinar for NIDA RFAs to support research to advance equity for racial and ethnic minority groups affected by disparities related to substance use and consequences of substance use
(NOT-DA-22-071)
- Notice of Change in the "NIDCD's Mentored Research Pathway for Otolaryngology Residents and Medical Students R25 Program (RFA-DC-20-002)" - Revision of the Number of Participants
(NOT-DC-22-010)
- Notice of Pre-Application Webinar for RFA-DE-23-006, RFA-DE-23-007, and RFA-DE-23-008, Data-Driven Tools to Accelerate the Clinical Translation of Novel Dental, Oral, and Craniofacial Biomaterials
(NOT-DE-22-016)
- Notice of Clarification of Applications Accepted to RFA-DK-20-032: Pilot and Feasibility Studies to Facilitate the Use of Diabetes Self-Management Education and Support to Improve Diabetes Care (R34 Clinical Trial Required)
(NOT-DK-22-026)
- Notice of Correction to the Application Types Allowed Information for PAS-22-197, Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
(NOT-AG-22-029)
- Notice of Early Expiration of RFA-AI-21-035, Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)"
(NOT-AI-22-052)
- Notice of Early Expiration of RFA-AI-21-020, Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)"
(NOT-AI-22-053)
- Notice of Early Expiration of "Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation", NOT-AI-22-056
(NOT-AI-22-066)
- Notice of Change to Key Dates for RFA-DA-23-032, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research at Minority Serving Institutions (R01 Clinical Trial Optional)"
(NOT-DA-22-067)
- Notice of Change to Key Dates for RFA-DA-23-013, "NIDA REI: Addressing Racial Equity in Substance Use and Addiction Outcomes Through Community-Engaged Research (R01 Clinical Trial Optional)
(NOT-DA-22-072)
- Notice of Participation of NIMH in NOT-DA-23-008,"Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes"
(NOT-MH-22-295)
- Notice of Correction to RFA-OD-22-014 Specialized Centers of Research Excellence (SCORE) on Sex Differences (U54 Clinical Trial Optional)
(NOT-OD-22-193)
- Closing October 28, 2022 and October 30, 2023 Application Receipt Dates for PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
(NOT-OH-22-007)
- Notice Regarding Changes to the Application Types Accepted under RFA-OH-22-002 "NIOSH Centers for Agricultural Safety and Health (U54)" for the October 2022 receipt date
(NOT-OH-22-008)
- Closing PAR-20-312: "NIOSH State Occupational Safety and Health Surveillance Program (U60)
(NOT-OH-22-009)
- Notice of Intent to Publish a Funding Opportunity Announcement for Pediatric Heart Network Clinical Research Centers (UM1)
(NOT-HL-22-045)
- Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Gender Inclusive Excellence (AGIE) Coordinating Center (U24 Clinical Trial Not Allowed)
(NOT-OD-22-204)
- Pre-Solicitation Notice: Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA), RFP: 75N93022R00015
(NOT-AI-22-073)
- Notice of Special Interest (NOSI): HEAL Initiative: Biospecimen Collection in Pregnancy
(NOT-DA-23-005)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities
- NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
(PAR-22-224)
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is September 25, 2020.
- NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Independent Clinical Trial Not Allowed)
(PAR-22-226)
Application Receipt Date(s): October 4, 2021.
- NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed)
(PAR-22-227)
Application Receipt Date(s): September 29, 2021.
- The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
(PAR-22-234)
Application Receipt Date(s): June 20, 2025
- Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
(PAR-22-235)
Application Receipt Date(s): November 10, 2022
- Catalyst Award for Early-Stage Investigators (ESIs) Pursuing Research on HIV Comorbidities, Coinfections, and Complications (DP1- Clinical Trial Optional)
(PAR-23-024)
Application Receipt Date(s): May 01, 2025
- Maintaining Immunity after Immunization (U01 Clinical Trial Not Allowed)
(RFA-AI-22-055)
Application Receipt Date(s): January 13, 2023
- REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
(RFA-AT-23-007)
Application Receipt Date(s): November 10, 2022
- Cancer Adoptive Cellular Therapy Network (Can-ACT) for Adult Cancers (UG3/UH3 Clinical Trial Required)
(RFA-CA-22-028)
Application Receipt Date(s): Multiple dates, see announcement.
- Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical Trial Required)
(RFA-CA-22-029)
Application Receipt Date(s): Multiple dates, see announcement.
- Cancer Adoptive Cellular Therapy Network (Can-ACT) Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-CA-22-030)
Application Receipt Date(s): October 28, 2022
- Drug Induced Liver Injury Network (DILIN) Clinical Centers (U01 - Clinical Trial Optional)
(RFA-DK-22-013)
Application Receipt Date(s): October 27, 2022
- Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed)
(RFA-DK-22-506)
Application Receipt Date(s): October 26, 2022
- Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network Scientific and Data Research Center (APOLLO SDRC) (Collaborative U01 - Clinical Trial Not Allowed)
(RFA-DK-22-507)
Application Receipt Date(s): Not Applicable
- Limited Competition for the Continuation of the Drug Induced Liver Injury Network Data Coordinating Center (DILIN) (U01 - Clinical Trial Not Allowed)
(RFA-DK-22-508)
Application Receipt Date(s): Not Applicable
- HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
(RFA-EB-22-002)
Application Receipt Date(s): June 17, 2025
- Physiomimetics and Organoids for Reproductive Health (R01 Clinical Trial Not Allowed)
(RFA-HD-23-024)
Application Receipt Date(s): March 29, 2023
- Physiomimetics and Organoids for Reproductive Health (R21 Clinical Trial Not Allowed)
(RFA-HD-23-025)
Application Receipt Date(s): March 29, 2023
- AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32)
(RFA-HS-22-010)
Application Receipt Date(s): December 01, 2022
- Optimization of Genome Editing Therapeutics for Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (U01 - Clinical Trials Not Allowed)
(RFA-NS-23-017)
Application Receipt Date(s): November 30, 2022
- Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
(RFA-OH-23-001)
Application Receipt Date(s): December 6, 2022
- AHRQ Conference Grant Programs (R13)
(PA-22-238)
Application Receipt Date(s): October 31, 2026
Other Funding Opportunities
Call for Applicants for Searle Scholar
The Searle Scholar Program (https://searlescholars.org/) has opened a 2023 award nomination. The Searle Scholars Program supports high risk, high reward research across a broad range of scientific disciplines. Grants are $300,000 for a three-year term with $100,000 payable each year of the grant. The Searle Scholars Program is funded through the Searle Funds at The Chicago Community Trust and administered by Kinship Foundation. Early tenure-track faculty are eligible to apply. Clinicians can apply but must have substantial research. They fund in all areas of research.
OUHSC can only submit one applicant. If you would like to be nominated, please send your CV, Biosketch, and a one-two page synopsis of your research areas of interest to Dr. Mary Beth Humphrey (marybeth-humphrey@ouhsc.edu) and Donna Emrick (donna-emrick@ouhsc.edu) by 5pm on Sept 1, 2022. A committee will review all applicants and select one to move forward.
OCAST - Oklahoma Health Research Program
Description: OCAST’s Oklahoma Health Research program funds basic research projects related to human health for one to three years at a maximum level of $45,000 per year. The awards enable researchers to gain the expertise and produce the data needed to obtain larger grants from federal agencies, private enterprises and non-profit funding organizations. All proposals are reviewed and ranked for funding by experienced health researchers who reside outside the state of Oklahoma. Peer reviewers evaluate applications for scientific merit based on the quality of the proposed research, qualifications of the principal investigator and appropriateness of the institutional facilities and use of the described project budget.
Full application: September 26, 2022
Link to Full Announcement: https://oklahoma.gov/ocast/research-funding/oklahoma-health-research.html
OCAST Oklahoma Health Research Postdoctoral Fellowship Program
Description: The Oklahoma Health Research program’s Postdoctoral Fellowship (Health Fellowship) Initiative funding is intended to improve the state’s health sciences R&D base by encouraging recent doctoral degree recipients to better prepare for scientific and technical-based careers in academia or high-tech companies in Oklahoma. OCAST fellowship funding acknowledges that the principal resources of the research institutions and companies are the people they employ, and this Initiative allows those entities to attract and/or retain the best candidates into established, successful health research facilities within Oklahoma.
Full application: September 26, 2022
Link to Full Announcement: https://oklahoma.gov/ocast/research-funding/health-research-postdoctoral-fellowship.html
OCAST - Intern Partnerships Program
Description: The purpose of the Student Intern Partnerships funding (Intern Award) is to improve the state’s innovation base by supporting internships in Oklahoma companies engaged in research, innovation development, or implementation of new technology, e.g., a manufacturing operation improving product or process through the implementation of new technology. The program encourages students to prepare for careers in scientific and technical fields as well as ancillary areas that support high-tech industry in Oklahoma.
Full application: September 26, 2022
Link to Full Announcement: https://oklahoma.gov/ocast/research-funding/intern-partnership.html
OCAST - Oklahoma Applied Research Support (OARS) Program
Description: This Funding Opportunity Announcement (FOA) is intended for informational purposes and reflects current planning. It does not obligate OCAST to make any specific number of awards. Awards under the Oklahoma Applied Research Support program are contingent upon the availability of state funds. If there is any inconsistency between the information contained in this FOA and the terms of any resulting contract, the terms of the contract are controlling.
Full application: September 26, 2022
Link to Full Announcement: https://oklahoma.gov/ocast/research-funding/oklahoma-applied-research-support.html
Melanoma Research Alliance (MRA) - 2022-2023 Request for Proposals
Description: The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.
Proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Awards, Young Investigator Awards, and Pilot Awards. Special Opportunities Included in RFP:
- Immunotherapy Young Investigator Awards supported by Bristol Myers Squibb (BMS)
- Radiation Oncology Young Investigator Award co-funded with the American Society for Radiation Oncology (ASTRO)
- Metastatic Uveal Melanoma Pilot Award co-funded with A Cure in Sight
- Patient-Centric Clinical Trials Team Science Awards co-funded with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR)
Deadline for Letters of Intent for RTFCCR-MRA Team Science Awards: October 5, 2022
Deadline for Young Investigator applicants to submit Applicant Eligibility Checklist: October 19, 2022
Deadline for all Individual Awards (EIA, YIA, and Pilot) proposals: November 2, 2022
Deadline for invited full applications for RTFCCR-MRA Team Science Awards: January 18, 2023
Link to Full Announcement: https://www.curemelanoma.org/research/request-for-proposals/mra-general-rfp/
The Cystic Fibrosis Foundation - Clinical Research Award
Description: Clinical Research Awards are offered to provide support for investigator-initiated clinical research projects that have the potential to make an important contribution to the Cystic Fibrosis Foundation’s mission. Research projects may address diagnosis, treatment, management of disease or symptom, or the pathophysiology of cystic fibrosis using clinical (observational/interventional), translational, or epidemiologic study approaches.